Allergan patent suit loss sends stock down 5%

Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.